Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.620
+0.040 (1.12%)
At close: Apr 1, 2026, 4:00 PM EDT
3.610
-0.010 (-0.28%)
Pre-market: Apr 2, 2026, 4:04 AM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $393.02 million as of April 1, 2026. Its market cap has decreased by -55.86% in one year.
Market Cap
393.02M
Enterprise Value
228.97M
1-Year Change
-55.86%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $393.02M, an increase of 312.40%. That is a compound annual growth rate of 13.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 393.00M | 3.45% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 405.93M |
| Lineage Cell Therapeutics | 396.05M |
| X4 Pharmaceuticals | 395.50M |
| Ginkgo Bioworks Holdings | 395.23M |
| XOMA Royalty | 394.05M |
| Century Therapeutics | 393.59M |
| Armata Pharmaceuticals | 386.84M |
| Avalo Therapeutics | 380.57M |